The international respiratory community gathered together to share the latest scientific data & findings on respiratory medicine at the ERS congress in September. Below you can find information on Orion Pharma's events during the congress. Please visit our Online Exhibition & Videos if you wish to watch the recordings. Please notice that the content is available only for prescribing healthcare professionals.
Professor Tari Haahtela, Professor Federico Lavorini and Professor Lauri Lehtimäki presented valuable aspects of respiratory therapy for asthma and COPD patients.
Inhaler carbon footprint and sustainability, Professor Tari Haahtela, Skin and Allergy Hospital, University of Helsinki, Finland
Digital solutions in asthma and COPD care, Professor Lauri Lehtimäki, Tampere University Hospital, Finland
Do not fear resistance, Professor Federico Lavorini, Dept. Experimental and Clinical Medicine, Careggi University Hospital Florence, Italy
Orion Pharma and Menarini organised together a virtual symposium on Monday 7th of September.
Introduction, Professor Eric Bateman
Why do some patients with COPD benefit from inhaled corticosteroid treatment? Professor Klaus Rabe
Key features of inhaler-device technology – what to consider and how to make it work for the patients? Professor Lauri Lehtimäki
Trainers and Trainees: how to ensure successful inhalation therapy for patients? Professor Omar Usmani
Changing perceptions and improving asthma outcomes: spotlight on MART, Professor Eric Bateman
Meeting summary & close
See detailed scientific program here
ERS declines all responsibility with respect to the information published in this document.
9 Sep 2020 
